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Abstract
Trichomonosis has been assessed according to the criteria of the Animal Health Law (AHL), in
particular criteria of Article 7 on disease proﬁle and impacts, Article 5 on the eligibility of trichomonosis
to be listed, Article 9 for the categorisation of trichomonosis according to disease prevention and
control rules as in Annex IV and Article 8 on the list of animal species related to trichomonosis. The
assessment has been performed following a methodology composed of information collection and
compilation, expert judgement on each criterion at individual and, if no consensus was reached before,
also at collective level. The output is composed of the categorical answer, and for the questions where
no consensus was reached, the different supporting views are reported. Details on the methodology
used for this assessment are explained in a separate opinion. According to the assessment performed,
trichomonosis can be considered eligible to be listed for Union intervention as laid down in Article 5(3)
of the AHL. The disease would comply with the criteria as in sections 3, 4 and 5 of Annex IV of the
AHL, for the application of the disease prevention and control rules referred to in points (c), (d) and
(e) of Article 9(1). The animal species to be listed for trichomonosis according to Article 8(3) criteria is
cattle as susceptible and reservoir.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
The background and Terms of Reference (ToR) as provided by the European Commission for the
present document are reported in Section 1.2 of the scientiﬁc opinion on the ad hoc methodology
followed for the assessment of the disease to be listed and categorised according to the criteria of
Article 5, Annex IV according to Article 9 and 8 within the Animal Health Law (AHL) framework (EFSA
AHAW Panel, 2017).
1.2. Interpretation of the Terms of Reference
The interpretation of the ToR is as in Section 1.2 of the scientiﬁc opinion on the ad hoc
methodology followed for the assessment of the disease to be listed and categorised according to the
criteria of Article 5, Annex IV according to Article 9 and 8 within the AHL framework (EFSA AHAW
Panel, 2017).
The present document reports the results of assessment on trichomonosis according to the criteria
of the AHL articles as follows:
• Article 7: trichomonosis proﬁle and impacts
• Article 5: eligibility of trichomonosis to be listed
• Article 9: categorisation of trichomonosis according to disease prevention and control rules as
in Annex IV
• Article 8: list of animal species related to trichomonosis.
2. Data and methodologies
The methodology applied in this opinion is described in detail in a dedicated document about the
ad hoc method developed for assessing any animal disease for the listing and categorisation of
diseases within the AHL framework (EFSA AHAW Panel, 2017).
3. Assessment
3.1. Assessment according to Article 7 criteria
This section presents the assessment of trichomonosis according to the Article 7 criteria of the AHL
and related parameters (see Table 2 of the opinion on methodology (EFSA AHAW Panel, 2017)), based
on the information contained in the fact-sheet as drafted by the selected disease scientist (see section
2.1 of the scientiﬁc opinion on the ad hoc methodology) and amended by the AHAW Panel.
3.1.1. Article 7(a) Disease Proﬁle
3.1.1.1. Article 7(a)(i) Animal species concerned by the disease
Susceptible animal species
Parameter 1 – Naturally susceptible wildlife species (or family/orders)
Not applicable – Tritrichomonas foetus has not been reported so far in wildlife species. An early
report in roe deer (Capreolus capreolus) has not been conﬁrmed.
Parameter 2 – Naturally susceptible domestic species (or family/orders)
Natural hosts of bovine T. foetus are cattle (Bos taurus) and zebu (Bos taurus indicus). The parasite
is located in the genital tract of cattle (Skirrow and BonDurant, 1988; BonDurant, 2005; Sager et al.,
2007) causing trichomonosis (syn. tritrichomonosis).
Despite T. foetus or similar (i.e. Tritrichomonas suis) species found infecting cats and pigs,
evidences from genetic and biology point of view suggest that there are no links between life cycles of
T. foetus in cattle and cats or between life cycles of feline or bovine T. foetus and porcine T. suis. Most
likely these parasites have evolved separately and despite their similarity, T. foetus of bovine and feline
origin as well as porcine T. suis show biological traits which differ considerably. Therefore, each form is
regarded as genetically distinct (Slapeta et al., 2010, 2012). More detailed information is provided
below.
AHL assessment on trichomonosis
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2017;15(10):4992
T. foetus has been conﬁrmed as the causative agent of chronic diarrhoea in the domestic cat
(Felis catus) (Gookin et al., 1999; Levy et al., 2003). There are also biological differences between
isolates from cattle and cats concerning pH tolerance (Morin-Adeline et al., 2015); route of
transmission (venereal versus faecal–oral), pathogenicity in experimental infections of uterus of cows
(Stockdale et al., 2007) and survival in invertebrate vectors (slugs) (Van der Saag et al., 2011). Thus,
some authors believe that feline T. foetus represents a different species and a change in name, to
Tritrichomonas blagburni, has been proposed (Walden et al., 2013).
Trichomonads are occasionally observed in the faeces from dogs (Canis familiaris) with diarrhoea
(Gookin et al., 2005). The parasite has also been detected in the faeces of puppies, indicating that
T. foetus may parasitise dogs (Grellet et al., 2010). Finally, T. foetus isolated from cattle seems to be
morphologically and genetically identical to Trichomonas suis, that is a commensal observed in the
nasal cavity, stomach, caecum and colon of the domestic pig (Sus scrofa domesticus) (Felleisen et al.,
1998; Hampl et al., 2001; Tachezy et al., 2002; Reinmann et al., 2012; Slapeta et al., 2012; Sun et al.,
2012). Consequently, it was assumed that T. suis and T. foetus belong to the same species (Tachezy
et al., 2002; Lun et al., 2005; Frey and M€uller, 2012; Yao and K€oster, 2015). However, more recent
epidemiological studies suggest that cross-species transmission from pigs to cattle on the same farm
(e.g. by exposure to T. foetus-contaminated pig faeces) is unlikely to occur (Mueller et al., 2015).
Parameter 3 – Experimentally susceptible wildlife species (or family/orders)
Not applicable – T. foetus has not been reported so far in wildlife species.
Parameter 4 – Experimentally susceptible domestic species (or family/orders) (Table 1)
Intravaginal T. foetus infection has been achieved in different laboratory animal models such as
golden hamster (Ryley and Stacey, 1963), mice with (St Claire et al., 1994) or without (Mutwiri and
Corbeil, 1998) oestrogen treatment prior to inoculation and in pregnant mice (Agnew et al., 2008;
Barbeito et al., 2008).
Reservoir animal species
Parameter 5 – Wild reservoir species (or family/orders)
Not applicable – conﬁrmed cases of T. foetus have not been described so far in wildlife species.
Parameter 6 – Domestic reservoir species (or family/orders)
Infection in bulls is reported to persist for more than 3 years and may persist for life (Flower et al.,
1983; Campero et al., 1990; Rhyan et al., 1999).
Carrier cows may represent a reservoir of infection for bulls. A very small proportion of cows (a
fraction less than 1%) in infected herds have been shown to remain infected throughout pregnancy,
and into the following breeding season (BonDurant, 2005). Carrier dams have been reported; e.g. two
chronically infected dams were observed in one Australian study 16 and 22 months after initial
infection (Alexander, 1953). In a Californian dairy herd, infected cows were found positive 9 weeks
after pregnancy (Skirrow, 1987) or 63 days after parturition (Goodger and Skirrow, 1986). In a more
recent study from Argentina, several heifers remained infected up to 300 days after breeding
(Mancebo et al., 1995).
Table 1: Domestic species susceptible to experimental T. foetus infection
Animal species
Inoculation
route
Infection/clinical signs Reference
Bos
taurus
Bulls Preputium Yes/asymptomatic and/or
mild lesions in preputial
mucosa
Clark et al. (1974)
Heifers
(non-pregnant)
Vagina Yes/vaginitis, cervicitis and
endometritis
Parsonson et al. (1976), Skirrow and
BonDurant (1990), BonDurant et al.
(1993), Anderson et al. (1996)
Felis
catus
Orogastric Yes/chronic or intermittent
large bowel diarrhoea
Gookin et al. (2001)
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3.1.1.2. Article 7(a)(ii) The morbidity and mortality rates of the disease in animal
populations
Morbidity
Parameter 1 – Prevalence/Incidence
Trichomonosis in bovine is a major problem worldwide, mainly in beef herds managed under
extensive conditions and where natural service is used. The infection has been described in all the
continents where cattle are raised, but the percentage of infected animals or herds varies widely
between regions. Prevalence is usually lower in areas where control programmes exist (Table 2).
In European Union (EU) countries, the disease presence has dramatically decreased in recent years
or even has been eradicated (in dairy cattle) due to the implementation of control programmes and
the use of artiﬁcial insemination (AI). A recent survey conducted in Switzerland involving 1,362
preputial samples from bulls and 60 abomasal ﬂuid samples of aborted fetuses from beef and dairy
herds revealed no T. foetus positive ﬁnding (Bernasconi et al., 2014). However, other studies suggest a
re-emergence of the disease in extensive production systems in southern Europe. In Spain, 32% of
the tested bulls were infected, positive at culture or by polymerase chain reaction (PCR) preputial
samples (Mendoza-Ibarra et al., 2012). It is to be noted that, since T. foetus infection is asymptomatic
in bulls, prevalence (percentage of bulls with a preputial sample positive by culture or PCR) is not
linked to morbidity in bulls. However, there is a positive association between bull infection rates and
the proportion of non-pregnant cows and heifers in a herd. The presence of trichomonosis was
reported to World Organization for Animal Health (OIE) by several countries in Europe (Table 3).
Table 2: Seroprevalence (agent isolation) of T. foetus in cattle throughout the world
Country Region Type of sample
% Herds
positive
% Animals
positive
Control
programme
References
Argentina Buenos Aires Preputial sample 24 NA No Mardones et al. (2008)
La Pampa Preputial sample 5.1 1.1 Yes Molina et al. (2013)
Australia Victoria River
district
Preputial sample 65.5 8 No McCool et al. (1988)
Brazil Pernambuco Cervico-vaginal
mucus sample
90.5 33.4 No Oliveira et al. (2015)
China Beijing Abomasal content
of aborted fetuses
NA 5 No Yang et al. (2012)
Costa
Rica
NA Preputial sample 18.4 7.2 No Perez et al. (1992)
South
Africa
North Western
Cape
Preputial sample NA 10.2 No Erasmus et al. (1989)
Spain Asturias Preputial sample 41.5 32 No Mendoza-Ibarra et al.
(2012)
Preputial sample 18.7–19.7 12.7–13.6 Yes Collantes-Fernandez
et al. (2014)
Turkey Anatolia Abomasal content
of aborted fetuses
NA 5.7 No Guven et al. (2013)
USA Texas Preputial sample NA 3.7 Yes Szonyi et al. (2012)
California Preputial sample 15.8 4.1 No BonDurant et al.
(1990)
Idaho Preputial sample 40.9 NA No Gay et al. (1996)
Florida Preputial sample 30.4 6 No Rae et al. (2004)
Wyoming Preputial sample NA 0.2 Yes Yao et al. (2011)
Cervico-vaginal
mucus sample
NA 9.7 Yes Yao (2015)
Alabama Preputial sample NA 0–0.27 No Rodning et al. (2008)
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Parameter 2 – Case-morbidity rate (% clinically diseased animals out of infected ones)
In males, after inoculation of T. foetus in 3–7-year old bulls, 92.3% of animals were infected (Clark
et al., 1974). However, T. foetus infection is asymptomatic in bulls and affects neither semen quality
nor sexual behaviour (Parsonson et al., 1974; Rhyan et al., 1999), thus morbidity rate is 0% for bulls.
However, there is a positive association between bull infection rates and the proportion of non-
pregnant cows and heifers in a herd.
Few data about percentage of clinically diseased cows in Europe are reported in the literature. In
infected herds, low overall pregnancy rate is noted and in newly exposed herds it can be as low as
50% of the expected rate (BonDurant, 2005). Distribution of cases in an infected herd was reported in
8% aborted cows, 2% pyometra, 60% infertility (late breeders), 20% infected cows without any losses
and 10% non-infected (NDA, online).
Mortality
Parameter 3 – Case-fatality rate
Infection causes no adult mortality; neither in bulls nor cows is fatal cases reported. Infection of
pregnant cattle can result in early fetal death. Abortions of fetuses typically occur about 2 months
gestational age (at > 42 days of gestation with a peak loss at 70–90 days) (Parsonson et al., 1976;
BonDurant, 2005). Fifty per cent of pregnant exposed cows which resulted positive subsequently
aborted (Kimsey, 1986).
3.1.1.3. Article 7(a)(iii) The zoonotic character of the disease
Only four reports of zoonotic cases are available in literature and they are the only cases reported
worldwide so far. In such cases, T. foetus-like organisms have been reported as opportunistic infections in
immunocompromised or immunosuppressed individuals (Okamoto et al., 1998; Duboucher et al., 2006;
Zalonis et al., 2011; Suzuki et al., 2016). Data on human cases have to be interpreted with care as only for
the most recent case described, was enough molecular data available to suspect infection with T. foetus.
It is suspected that some of those cases were caused by the T. foetus cattle/swine genotype based on
molecular characterisation. The symptoms and location of lesions differed largely in the human cases
reported; T. foetus-like tritrichomonads have been detected in cerebrospinal ﬂuid (meningoencephalitis)
(Okamoto et al., 1998), broncheoalveolar lavage specimens (pneumonia) (Duboucher et al., 2006),
peritoneal ﬂuid (peritonitis) (Zalonis et al., 2011) and biliary tract (Suzuki et al., 2016).
3.1.1.4. Article 7(a)(iv) The resistance to treatments, including antimicrobial resistance
Parameter 1 – Resistant strain to any treatment even at laboratory level
In the past, various imidazole compounds (metronidazole, dimetridazole and ipronidazole) were
used to treat T. foetus-infected bulls, and drug resistant strains to these imidazole compounds were
found (BonDurant, 2005; Rae and Crews, 2006). Currently, there is no approved treatment for cattle
infected with T. foetus because of concerns regarding toxic residues in meat (BonDurant, 1997).
3.1.1.5. Article 7(a)(v) The persistence of the disease in an animal population or the
environment
Animal population
Parameter 1 – Duration of infectious period in animals
The infected bull acts as an asymptomatic carrier throughout his life (Clark et al., 1974; Parsonson
et al., 1974; Parker et al., 1999).
In the female, 2 weeks after infection, T. foetus may have colonised the different parts of the
genital tract (Parsonson et al., 1976). In the female, the infection is self-limiting and most cows are
able to clear the infection after a few months, usually after 1–3 months, rarely longer (Parsonson
et al., 1976; Skirrow and BonDurant, 1990; BonDurant, 2005), which can be considered the normal
duration of the infectious period in females (see Section 3.1.1.1 Parameter 5 and Parameter 3 below
for reported exceptions to this normality). The preferred location is in the cervix and cervico-vaginal
mucus, but the number of parasites varies throughout the oestrus cycle, being higher in the days prior
to oestrus. The establishment of the parasite in the genital tract of the female does not seem to
interfere with the fertilisation nor with the early development of the embryo (Bielanski et al., 2004). In
heifers, experimentally infected with T. foetus, conceptus deaths peaked at 50–70 days of gestation
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(Parsonson et al., 1976). Occasional abortions of fetuses older than 4 month gestational age are
reported, but typically losses occurs 2 months earlier (BonDurant, 2005).
Parameter 2 – Presence and duration of latent infection period
Bulls remain persistently infected for more than 3 years and infection may persist for life (Flower
et al., 1983; Campero et al., 1990; Rhyan et al., 1999; BonDurant, 2005).
The infection in the female is usually self-limiting, disappearing between 2 and 4 months after the
loss of the conceptus with some reported exceptions. The immunity that develops is not permanent
and usually lasts for about 6 months; after 6 months, the female is again susceptible to infection
(Parsonson et al., 1976; BonDurant, 2005).
Parameter 3 – Presence and duration of the pathogen in healthy carriers
Infection in bulls is asymptomatic and persists for more than 3 years and probably for life (Flower
et al., 1983; Campero et al., 1990; Rhyan et al., 1999). Bulls younger than 4 years are less often
carriers of T. foetus (Kimsey et al., 1980; BonDurant, 1985; Skirrow et al., 1985; BonDurant et al.,
1990; Perez et al., 1992; Ondrak, 2016).
Carrier dams have been reported; not all cows are able to clear infection prior to re-breeding and
some remain infected for up to almost 1 year, even after parturition (Alexander, 1953; Goodger and
Skirrow, 1986; Skirrow, 1987; Mancebo et al., 1995). These cows represent carrier cows, e.g. two
chronically infected dams were observed in one Australian study 16 and 22 months after initial infection
(Alexander, 1953). In a Californian dairy herd, infected cows were found positive 9 weeks after pregnancy
(Skirrow, 1987) or 63 days after parturition (Goodger and Skirrow, 1986). In a more recent study from
Argentina, several heifers remained infected up to 300 days after breeding (Mancebo et al., 1995) which
underlines the importance of carrier state heifers for persistence of infection in affected herds.
Environment
Parameter 4 – Length of survival (dpi) of the agent and/or detection of DNA in selected matrices (soil,
water, air) from the environment (scenarios: high and low T)
Bovine T. foetus is considered incapable of forming cysts and viability of the parasite in the
environment is very limited (BonDurant and Honigberg, 1994).
3.1.1.6. Article 7(a)(vi) The routes and speed of transmission of the disease between
animals, and, when relevant, between animals and humans
Routes of transmission
Parameter 1 – Types of routes of transmission from animal to animal (horizontal, vertical)
Trichomonosis in bovine is horizontally transmitted and vertical transmission plays no role in the
spread of the disease. Transmission of the infection during pregnancy to the embryo or the foetus may
result in embryonic death, resorption or abortion.
Trichomonosis is a venereal disease transmitted from an infected bull to an uninfected dam or vice
versa (Ondrak, 2016) almost exclusively during coitus. In general, a transmission rate of 30–70%
between infected bulls and female cattle is assumed (BonDurant, 2005); however, a single mating with an
infected bull may result in an up to 95% infection rate among susceptible heifers (Parsonson et al., 1976).
Mechanical transmission, either by uninfected bulls (Clark et al., 1977; Ondrak, 2016) or iatrogenic,
e.g. using the same glass rod or insemination pipette for different cows (Murname, 1959), not properly
disinfected specula (Goodger and Skirrow, 1986) or contaminated cryopreserved semen (Blackshaw
and Beattie, 1955; Clark et al., 1971; Skirrow and BonDurant, 1988) seems to be possible but the
frequency of these events is very rare. Mechanical transmission seems to be possible through a
healthy bull, i.e. from an infected cow to a receptive cow, if there is not too much time between two
services (less than 20 minutes) (Clark et al., 1977; Goodger and Skirrow, 1986; Ondrak, 2016).
There is no evidence to support the persistence of T. foetus in the environment and its further
transmission to susceptible animals.
Parameter 2 – Types of routes of transmission between animals and humans (direct, indirect, including
food-borne)
To date, only few cases of human trichomonosis caused by T. foetus of the cattle/swine genotype
have been reported, as rare opportunistic infections in immunosuppressed or immunologically impaired
AHL assessment on trichomonosis
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individuals (Okamoto et al., 1998; Duboucher et al., 2006; Zalonis et al., 2011; Suzuki et al., 2016).
Routes of infection are unknown and it was suspected that individuals with intestinal damage due to
pre- or co-infection with another agent are susceptible after oral infection (Suzuki et al., 2016).
Speed of transmission
Parameter 3 – Incidence between animals and, when relevant, between animals and humans
There are no ﬁgures on incidence in literature.
Parameter 4 – Transmission rate (beta) (from R0 and infectious period) between animals and, when
relevant, between animals and humans
A precise transmission rate has not yet been determined. There is no literature available reporting
on ‘beta’. Statistical modelling was performed with assumptions regarding transmission rates based on
literature data (Villarroel et al., 2004). When a bovine herd did not test bulls for trichomonosis before
the breeding season, a triangular probability distribution for both, young bulls (minimum, 0%; mode,
5%; maximum, 40%) and old bulls (minimum, 0%; mode, 35%; and maximum, 80%) to transmit an
existing infection to non-infected dams was assumed. For a transmission from infected cows to
susceptible bulls, a triangular distribution of probabilities (minimum, 0%; mode, 0%; maximum, 50%)
was assumed for young bulls and a uniform probability distribution for old bulls (minimum, 50%;
maximum, 100%) (Villarroel et al., 2004).
3.1.1.7. Article 7(a)(vii) The absence or presence and distribution of the disease in the
Union, where the disease is not present in the Union, the risk of its introduction
into the Union
Presence and distribution
Trichomonosis has been reported to the OIE in the last 5 years in countries from the EU such as
Spain, Portugal, France, Hungary and Poland (Table 3).
Table 3: Trichomonosis status in Countries in Europe based on World Animal Health Information
Database (WAHIS Interface) from 2012 to 2016
EU country 2012 2013 2014 2015 2016
Albania No information
available
No information
available
Infection limited
to one or more
zones
Disease present Infection
Austria No information
available
No information
available
No information
available
No information
available
No information
available
Belgium Disease absent Infection Disease absent Disease absent Disease absent
Bosnia and
Herzegovina
Disease absent Disease absent Disease absent Disease absent Disease absent
Bulgaria No information
available
No information
available
Disease absent Disease absent Disease absent
Croatia Disease absent Disease absent Disease absent Disease absent Disease absent
Cyprus Disease absent Disease absent Disease absent Disease absent Disease absent
Czech Republic Disease absent Disease absent Disease absent Disease absent Disease absent
Denmark Disease absent Disease absent Disease absent Disease absent Disease absent
Estonia Disease absent Disease absent Disease absent Disease absent Disease absent
Finland Disease absent Disease absent Disease absent Disease absent Disease absent
France Disease present Disease present Disease present Disease present Disease present
Germany Disease absent Disease absent Disease absent Disease absent Disease absent
Greece Disease absent Disease absent Disease absent Disease absent No information
available
Hungary Disease limited to
one or more
zones
Disease limited to
one or more
zones
Disease limited to
one or more
zones
Disease limited
to one or more
zones
Disease absent
Ireland No information
available
No information
available
No information
available
No information
available
No information
available
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Parameter 2 – Type of epidemiological occurrence (sporadic, epidemic, endemic) at MS level
In the EU, the use of AI and effective control programmes have greatly reduced the incidence of
trichomonosis in bovine and the disease is largely eradicated in dairy cattle herds. The infection is
limited to beef cattle making use of natural mating. No information is available about the
epidemiological occurrence of the infection in European countries where the disease has been reported
to the OIE (i.e. France, Portugal, Hungary and Poland, see Table 3), except for some regions of Spain
where the disease is endemic (Mendoza-Ibarra et al., 2012, 2013).
Risk of introduction
Parameter 3 – Routes of possible introduction
The disease can be introduced by the trade in animals, both males and females with unknown
health status. In the EU, there are no global mandatory regulations for cattle movements with regard
to trichomonosis in bovine. Recommendations for the importation of cattle and bulls for breeding can
be found in the OIE Terrestrial Animal Health Code. In particular, this includes testing bulls and
allowing the importation of T. foetus-free bulls only for reproductive purposes. Positive bulls need to be
culled (Yao, 2013).
The disease can be also introduced by semen trade used for AI due to the fact that T. foetus may
be present in semen if it is contaminated with preputial ﬂuid during manual collection (BonDurant,
2005) and the parasite can survive the freezing process used to preserve semen. In the EU, speciﬁc
regulations are applied to bovine semen trade and to administer the sanitary conditions required for
collection centres and the animals (see Section 3.1.4.5).
Parameter 4 – Number of animal moving and/or shipment size
Numbers of live cattle for breeding purpose and bovine semen trade between EU countries and
from third countries into the EU can be consulted in TRACES (TRACES, online).
EU country 2012 2013 2014 2015 2016
Italy Disease absent Infection/
infestation limited
to one or more
zones
Disease absent Infection/
infestation
limited to one or
more zones
Disease absent
Latvia Never reported Never reported Never reported Never reported Never reported
Lithuania Disease absent Disease absent Disease absent Disease absent Disease absent
Luxembourg Disease absent Disease absent Disease absent Disease absent No information
available
Malta Never reported Never reported Never reported Never reported Never reported
Montenegro Disease absent Disease absent Disease absent No information
available
No information
available
Netherlands Infection Infection Infection Infection Infection
Norway Disease absent Disease absent Disease absent Disease absent Disease absent
Poland Infection Disease absent Disease absent Disease absent Disease absent
Portugal Disease absent Disease absent Disease absent Disease present Disease present
Romania Disease absent Disease absent Disease absent Disease absent Disease absent
Serbia Disease absent Disease absent Disease absent Disease absent No information
available
Slovakia Disease absent Disease absent Disease absent Disease absent Disease absent
Slovenia Never reported Never reported Never reported Never reported Never reported
Spain Disease limited to
one or more
zones
Disease limited to
one or more
zones
Disease limited to
one or more
zones
Disease limited
to one or more
zones
Disease limited
to one or more
zones
Sweden Never reported Never reported Never reported Never reported Never reported
Switzerland Disease absent Disease absent Disease absent Disease absent Disease absent
United Kingdom Disease present Disease present Disease present Disease present Disease present
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Parameter 5 – Duration of infectious period in animal and/or commodity
Bulls can shed the parasite indeﬁnitely (Parsonson et al., 1974; Rhyan et al., 1999).
In the female, the infection is self-limiting and, with some exceptions, the parasite normally
disappears simultaneously from all areas of the genital tract after a period of at least 90–95 days
(Parsonson et al., 1976; Rae et al., 2004; BonDurant, 2005). A low percentage (about 1%) of the
dams remains infected until the next breeding period, and so is still able to infect bulls.
Parameter 6 – List of control measures at border (testing, quarantine, etc.)
There are no global mandatory regulations for cattle movement with regard to trichomonosis.
Parameter 7 – Presence and duration of latent infection and/or carrier status
The infected bulls remain asymptomatic carriers representing a permanent source of infection. A
very small proportion of cows (a fraction less than 1%) in infected herds have been shown to remain
infected throughout pregnancy, and in the following breeding season, also representing carrier animals
(BonDurant, 2005).
Parameter 8 – Risk of introduction
The disease is already present in the EU.
3.1.1.8. Article 7(a)(viii) The existence of diagnostic and disease control tools
Diagnostic tools
Parameter 1 – Existence of diagnostic tools
Optimal for the diagnosis of trichomonosis is the diagnostic cultivation of the sampled material
followed by daily microscopic examination of the culture to observe and characterise multiplying
trichomonads. Several media have been used successfully (OIE, 2017a). Transport and cultivation kits
are commercially available (e.g. InPouch TF, BioMed Diagnostics, White City, OR, USA). The identity of
cultivated trichomonads can be conﬁrmed after ﬁxation and staining (Lun and Gajadhar, 1999) or
optimally by PCR to avoid false positives (Parker et al., 2001; Campero et al., 2003).
Alternatively, sampled material can be analysed for parasitic DNA without prior cultivation. A large
number of PCRs have been reported. The majority of diagnostic PCRs published are targeting the DNA
coding for ribosomal ribonucleic acid (rRNA) and ﬂanking regions (recombinant DNA (rDNA)). This
rDNA region includes the 18S rDNA (small subunit rDNA (SSU rDNA)), the internal transcribed spacer
(ITS) 1 region, the 5.8S rDNA, the ITS2 and the 28S rDNA (large subunit rDNA (LSU rDNA)).
Both diagnostic conventional end-point PCRs and diagnostic real-time PCRs (e.g. SYBR green-
based, 50 nuclease assays) have been developed for the detection of trichomonads (Table A.1 in
Appendix A). Because rDNA shows only limited differences between trichomonads (Felleisen, 1997),
end-point assays have been applied using primer pairs capable to amplify DNA of several trichomonad
species simultaneously. In these PCRs, species diagnosis was achieved in a second step, either by PCR
restriction fragment length polymorphism (RFLP) (Hayes et al., 2003), by determining the precise size
of ampliﬁcation products (Grahn et al., 2005; Frey et al., 2009) or by single-strand conformation
polymorphism (SSCP) (Huby-Chilton et al., 2009). One of the ﬁrst diagnostic end-point PCRs
established and targeting rDNA, i.e. the TFR3/TRF4 PCR (Huby-Chilton et al., 2009) was modiﬁed by
several groups. A single-tube nested PCR was established using the TFR3/TRF4 primer pair for the
external ampliﬁcation (Gookin et al., 2002). The TFR3/TRF4 PCR was also modiﬁed as a SYBR®-based
real-time PCR (Mueller et al., 2015). A 50-nuclease assay (i.e. a real-time PCR applying a Taqman
probe) based on rDNA sequences has been established to detect T. foetus, T. suis and
Tritrichomonas mobilensis (McMillen and Lew, 2006). In this assay, a 57 bp region of the 5.8S region is
ampliﬁed. In addition, a commercialised 50-nuclease assay has been developed (VetMAXTM-Gold Trich
Detection Kit, Life Technologies) (Efﬁnger et al., 2014), which has been used in epidemiological studies
on T. foetus from cattle in southern Africa (Casteriano et al., 2016).
Direct microscopic examination without prior cultivation is possible but not recommended due to
low sensitivity. Attempts to detect speciﬁc antibodies against the parasite have been reported;
however, due to both sensitivity and speciﬁcity problems, serological tests are not used for routine
testing. Of minor importance are antigen detection and DNA hybridisation techniques which have been
applied as research tools mainly.
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Control tools
Parameter 2 – Existence of control tools
Prevention and control measures are based on the distinctive epidemiologic features of
trichomonosis in bovine, a sexually transmitted disease where infected bulls are asymptomatic carriers
and represent a permanent source of infection while in heifers and cows infection is typically transient
(Clark et al., 1971, 1974; Parsonson et al., 1974; Skirrow and BonDurant, 1990).
In the EU, speciﬁc regulations are applied to bovine semen trade and to regulate the sanitary
conditions of the collection centre and the animals (Council Directive 88/407/EEC1 as amended by
Council Directive 2003/43/EC2). Each Member State ensures that the semen sent from its territory to
another Member State is collected from bovine admitted and kept at an approved semen collection
centre that has been subjected to a period of quarantine (at least 28 days) and tested for T. foetus
initially according to their age and afterward once a year (Council Directive 2003/43/EC). Third
countries from which Members States can authorise imports into the Union of semen of the bovine
species are listed in the Commission Implementing Decision 2011/630/EU3 laying down animal health
conditions and certiﬁcation requirements for the imports of bovine semen into the Union.
T. foetus may be present in semen if it became contaminated with preputial ﬂuid during manual
collection (BonDurant, 2005); recommendations for the importation of cattle and bulls for breeding can
be found in the Terrestrial Animal Health Code. In particular, emphasis has been placed in the
measures applied to bull semen donor health status to avoid dissemination and transmission of the
disease (OIE, 2017b).
In dairy herds and in some beef herds, AI is a very useful measure to reduce and eliminate
infection. For bulls destined for AI, quarantine and periodic testing are required. It is of great value to
know the country of origin, the reproductive history of the bull, and the tests performed by the
artiﬁcial insemination centre (Eaglesome and Garcia, 1997).
In herds where it is not possible to introduce AI and natural mating is the normal practice, as in
many areas where beef cattle are raised extensively, the following measures are recommended:
Measures to prevent the entrance of disease in trichomonosis free-herds
• Quarantine and testing replacement bulls: Replacement should be done by virgin animals or
bulls acquired only from disease-free herds with records of excellence in reproductive
performance (Campero and Gottstein, 2007; Yao, 2013; Ondrak, 2016). All the bulls must be
tested during quarantine before entrance in the herd. If the bull comes from a trichomonosis-
free herd, the analysis of two samples of preputial smegma with 1–2 weeks interval during the
quarantine is recommended. Three or more samples must be analysed if bulls are provided
from an area where trichomonosis is known to be endemic.
• Avoid communal grazing (mixing animals form different herds) and keep fences in good
conditions: These measures will help to control the primary route of transmission (Gay et al.,
1996; Mardones et al., 2008; Jin et al., 2014).
• Do not introduce cows or heifers of unknown health status during the breeding season. Similar
to bulls, heifers and cows must be acquired only from disease-free herds with records of
excellence in reproductive performance.
Measures to control and eradicate trichomonosis in infected herds
• Analysis of bulls before the breeding season and culling of infected bulls: It is recommended to
sample the animal two or three times before the breeding season and every time new bulls are
introduced into the herds (BonDurant, 2005; Campero and Gottstein, 2007; Yao, 2013).
• Reduce the average age of bulls and replace all bulls after four breeding seasons: Replacement
with negative-tested young bulls helps to reduce the prevalence (Clark et al., 1971;
Christensen et al., 1977) since 3-year-old bulls seem to be not as susceptible as older bulls in
natural service (Clark et al., 1974).
1 Council Directive 88/407/EEC of 14 June 1988 laying down the animal health requirements applicable to intra- Community
trade in and imports of deep-frozen semen of domestic animals of the bovine species. OJ L 194, 22.7.1988, p. 10–23.
2 Council Directive 2003/43/EC of 26 May 2003 amending Directive 88/407/EEC laying down the animal health requirements
applicable to intra-Community trade in and imports of semen of domestic animals of the bovine species. OJ L 143, 11.6.2003,
p. 23–32.
3 Commission Implementing Decision of 20 September 2011 on imports into the Union of semen of domestic animals of the
bovine species (notiﬁed under document C(2011) 6426) (Text with EEA relevance) (2011/630/EU).
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• Pregnancy examination: All open (i.e. non-pregnant) and aborted cows should be culled or
segregated in high-risk sub-herds or groups (Campero and Gottstein, 2007).
• Use of commercial vaccines: Vaccination of all heifers and cows is a good measure to improve
reproductive efﬁciency mainly when risk factors associated to infection cannot be avoided.
Inactivated vaccines are available in the Americas, but not in the EU. These vaccines offer an
improvement in reproductive efﬁcacy (Kvasnicka et al., 1989, 1992; Edmondson et al., 2017).
• Segregation of the herd in low- and high-risk subherds or groups: In the low-risk subherds,
only dams that have recently calved are pregnant for more than 5 months and virgin females
must be included. These must be serviced preferably by virgin bulls or by bulls with two
negative tests and coming from negative herds. In order to be able to follow the effect of the
infection, the same group of females should be serviced with the same male until the disease
is controlled (Campero and Gottstein, 2007).
• Limit breeding season: The breeding season should be restricted to less than 4 months to
reduce the duration of a possible transmission period as much as possible. In addition, with a
shortened breeding season it becomes easier to monitor reproductive performance.
3.1.2. Article 7(b) The impact of diseases
3.1.2.1. Article 7(b)(i) The impact of the disease on agricultural and aquaculture
production and other parts of the economy
The level of presence of the disease in the Union
Parameter 1 – Number of MSs where the disease is present
Trichomonosis is limited to beef cattle from some parts of the EU where cattle are breeding by
natural service. The presence of the disease has been reported in beef cattle in Spain where the bull
prevalence can vary from 4% to 30% (Mendoza-Ibarra et al., 2012, 2013). In addition, the infection
has been notiﬁed to the OIE in Portugal, France, Hungary and Poland (see Table 3). Currently, there
are no monitoring programmes to track the incidence and prevalence of trichomonosis in bovine in
Europe. This lack of monitoring and reporting, in combination with inconsistent testing practices, can
lead to underestimate the true prevalence and adverse effects of the disease.
The loss of production due to the disease
Parameter 2 – Proportion of production losses (%) by epidemic/endemic situation
Trichomonosis decreases productivity of cattle by inducing reduced conception rates and calf crops,
increased days to conception, extended calving seasons, increased costs of replacement bulls, loss of
genetic potential due to culling, and lighter weaning weights (Clark et al., 1983b; Rae, 1989;
Collantes-Fernandez et al., 2014; Michi et al., 2016). It is estimated that beef herds with 20–40%
T. foetus-positive bulls had a reduction of 14–50% in annual calf crops and an increase of 5–35% in
the return to service per cow (Rae, 1989). In a study carried out in a local breed of cattle managed
using traditional systems from northern Spain (Collantes-Fernandez et al., 2014), T. foetus infection
increased calving intervals and reduced calf crop. On average, the infected herds required 79 days
longer between subsequent calvings and calf production was reduced by 17–18%. The largest losses
occur in the ﬁrst (reduction of 17.6% in calf production) and second (28.6%) years when cows
experience primary infection (Clark et al., 1983b). In addition, trichomonosis was reported to cause a
5–12% reduction in weight gain during the sucking/growing period and 4–10% reduction in weaning
weights (Michi et al., 2016). Speciﬁcally, in a recent study carried out in northern Spain, calves from
infected cows were born 35 days later, being nearly 26 kg lighter at weaning (Collantes-Fernandez
et al., 2014). In previous studies following the resolution of infection in a herd, increases in calving
percentages to 90% (Ball et al., 1987) and pregnancy percentages from 74% to 85% (Skirrow et al.,
1985) were described.
In the modern dairy industry, it appears that more than 90% of dairy calves are born to AI. For
example in Denmark in 2015, around 17% of ﬁrst parity dairy cows and 7% of older dairy cows were
bred using natural service, with the balance using AI and overall for dairy cattle, 90% are inseminated
using AI (SEGES, 2016). Similarly in France, 79% of births in dairy herds are by AI (IDELE, 2017). In
Ireland, extrapolated data from the Irish Cattle Breeding Federation indicate approximately 45-60% of
calves from the dairy herds are sired by AI (ICBF, 2017). According to the German Cattle Breeders’
Federation, in Germany around 25% of cattle farms use AI (ADR, 2016), most probably those are
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almost all farms keeping dairy cows. In the Netherlands, in 2016 approximately 225 000 natural
matings were registered as compared to 1.6 million ﬁrst AI. In Finland, dairy herds are bred using AI
even if in some larger herds also natural mating is used.
Therefore, the economic losses due to trichomonosis in the EU are mostly linked to the beef cattle
sector where natural mating is used. Most of the meat bovine herd in Europe is located in four EU
Member States: France (34.4%), Spain (15.2%), the UK (12.8%) and Ireland (8.7%). Together, they
host more than 70% of the European meat herd (EUROSTAT, online). In France, only 13% of beef
cattle are bred from AI (IDELE, 2017). In UK, the majority of beef herds use natural service. AI in beef
cows is still uncommon in the UK due to the problems of heat detection and handling for AI (Penny,
2017). In Ireland, only about 23% of calves in beef herds are bred by AI (Agriland, online) and around
80 000 beef stock bulls were present during 2016 (ICBF, 2017). In Italy, data from the National Data
Bank on farm animals indicate 17% ‘linea vacca-vitello’ beef cows representing 900 000 animals are
bred by natural service (BDN, online). In Spain, around 95% of beef cattle use natural services
(UGAVAN, 2017).
Thus, natural services account for a very considerable proportion of the beef cows born annually in
the EU.
3.1.2.2. Article 7(b)(ii) The impact of the disease on human health
Transmissibility between animals and humans
Parameter 1 – Types of routes of transmission between animals and humans
A few cases of T. foetus infections have been reported in humans. Routes of infections are
unknown. In the most recent case description, the oral route of infection was hypothesised (Suzuki
et al., 2016).
Parameter 2 – Incidence of zoonotic cases
No data are available. Only four case reports are available in literature.
Transmissibility between humans
Parameter 3 – Human to human transmission is sufﬁcient to sustain sporadic cases or community-level
outbreak
Not applicable – there is no evidence for a transmission of T. foetus between humans.
Parameter 4 – Sporadic, endemic, or pandemic potential
A sporadic pattern for T. foetus infections in humans is the most likely scenario.
The severity of human forms of the disease
Parameter 5 – Disability-adjusted life year (DALY)
No data available.
The availability of effective prevention or medical treatment in humans
Parameter 6 – Availability of medical treatment and their effectiveness (therapeutic effect and any
resistance)
No data available.
Parameter 7 – Availability of vaccines and their effectiveness (reduced morbidity)
No data available. No vaccinations are currently available.
3.1.2.3. Article 7(b)(iii) The impact of the disease on animal welfare
Parameter 1 – Severity of clinical signs at case level and related level and duration of impairment
In cows or heifers following infection at breeding, the parasite multiplication in the reproductive
tract causes inﬂammation of the endometrium, cervical and vaginal mucous membranes (Parsonson
et al., 1976; Rhyan et al., 1988; Anderson et al., 1996). Consequently, infection of pregnant cattle can
result in early embryonic death, resorption, abortion, pyometra, fetal maceration or infertility
(Anderson et al., 1996). Abortions of fetuses typically occur about 2 months gestational age (at
> 42 days of gestation with a peak loss at 70–90 days) (Parsonson et al., 1976; BonDurant, 2005).
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3.1.2.4. Article 7(b)(iv) The impact of the disease on biodiversity and the environment
Biodiversity
Not applicable – T. foetus has not been reported in wildlife species so far.
Environment
Parameter 3 – Capacity of the pathogen to persist in the environment and cause mortality in wildlife
T. foetus is considered incapable of forming cysts and has limited survival capacity outside the host
(BonDurant and Honigberg, 1994). However, the formation of pseudocysts has been reported (Pereira-
Neves and Benchimol, 2009).
T. foetus was shown to be able to survive in cryopreserved semen (Blackshaw and Beattie, 1955;
Clark et al., 1971) and may be present in semen if it is contaminated with preputial ﬂuid during
manual collection. Given the resistance of this parasite in fresh, pure or diluted semen, refrigerated
and even cryopreserved, there is the possibility of transmission through AI with contaminated semen
(BonDurant, 2005). T. foetus has not been reported so far in wildlife species, hence no mortality is
described.
3.1.3. Article 7(c) Its potential to generate a crisis situation and its potential use
in bioterrorism
Parameter 1 – Listed in OIE/CFSPH classiﬁcation of pathogens
Trichomonosis belongs to the OIE-listed Diseases.
Trichomonosis is not included in the CFSPH classiﬁcation of pathogens.
Parameter 2 – Listed in the Encyclopaedia of Bioterrorism Defence of Australia Group
T. foetus is not included in the Encyclopaedia of Bioterrorism Defence of Australia Group.
Parameter 3 – Included in any other list of potential bio- agro-terrorism agents
No – no speciﬁc list identiﬁed.
3.1.4. Article 7(d) The feasibility, availability and effectiveness of the following
disease prevention and control measures
3.1.4.1. Article 7(d)(i) Diagnostic tools and capacities
Availability
Parameter 1 – Ofﬁcially/internationally recognised diagnostic tool, OIE certiﬁed
The prescribed test for international trade is the identiﬁcation of T. foetus in bovine samples by
cultivation in combination with a microscopic examination and identiﬁcation of cultured trichomonads.
The examination of samples by PCR methods are mentioned as alternatives for diagnosis (OIE,
2017a).
The OIE Terrestrial Manual provides protocols for sampling, sample transportation, transport
medium, culture media or conditions, how to read out the culture test and recommendations for PCR
analyses.
No diagnostic kits for trichomonosis are listed on the register of diagnostic kits certiﬁed by the OIE
as validated as ﬁt for purpose. To the best of our knowledge, one T. foetus real-time PCR is
commercially available (VetMAXTM-Gold Trich Detection Kit, Life Technologies).
Other diagnostic procedures, like direct microscopic examination or antibody testing, are not
recommended as diagnostic tools due to low diagnostic sensitivity and low speciﬁcity.
Effectiveness
Parameter 2 – Se and Sp of diagnostic test
Diagnostic sensitivity (Se) of culture: The diagnostic sensitivity of a single culture test on infected
bulls has been estimated at 70–100% (Skirrow et al., 1985; Sch€onmann et al., 1994; Parker et al.,
1999, 2003a,c). A repeated testing of bulls (e.g. three times with intervals of several days) was shown
to increase the sensitivity of the cell culture test up to close to 100% (Mukhufhi et al., 2003).
Furthermore, consecutive testing over a period of more than 7 months demonstrated infection in
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100% of 15 infected bulls in another study (Clark et al., 1971). A sexual rest of bulls for a minimum of
about one to two weeks prior to sampling increases sensitivity (Yule et al., 1989).
Also for female cattle (i.e. the examination of cervico-vaginal mucus), the diagnostic sensitivity of a
single culture test has been reported in the range of 56–95% (Parsonson et al., 1976; Goodger and
Skirrow, 1986; Skirrow and BonDurant, 1988; Kittel et al., 1998). The infection in females is usually
cleared within 3 months and it may be difﬁcult to isolate organisms from female cattle in the late
stage of their infection, also because of ﬂuctuating concentrations of parasites during this period.
Diagnostic speciﬁcity (Sp) of culture: The diagnostic speciﬁcity of the culture method is lower than
100% (OIE, 2017a). It is difﬁcult and sometimes not possible to distinguish trichomonad species by
morphological criteria. Intestinal trichomonads were observed in virgin bull samples submitted for
conﬁrmation of culture diagnosis (BonDurant et al., 1999; Campero et al., 2003; Michi et al., 2016). A
subsequent PCR analysis of culture positive samples has been recommended to avoid false positive
ﬁndings (Parker et al., 2001; Campero et al., 2003).
Diagnostic sensitivity (Se) of PCR: The diagnostic sensitivity of PCR seems to be at least similar to
that of culture (Campero et al., 2003; Yao, 2013; OIE, 2017a). PCR can be used to rule out false-
positive cultures in bulls, especially in virgin bulls because viability of parasites is not a necessary
prerequisite of this technique (Campero et al., 2003; Parker et al., 2003b; Corbeil et al., 2008). Due to
PCR inhibiting contaminations or inefﬁcient DNA extraction, analytical sensitivity of PCR might be much
lower and is reported to be around ≤ 100 organisms per sample (Mukhufhi et al., 2003; Yao, 2013).
Control systems to monitor PCR inhibition are necessary; one commercially available T. foetus real-time
PCR kit includes an inhibition control (VetMAXTM-Gold Trich Detection Kit, Life Technologies).
Diagnostic speciﬁcity (Sp) of PCR: Diagnostic PCRs published are targeting the DNA coding for
rRNA and ﬂanking regions (rDNA). Because rDNA shows only limited or no differences between
trichomonads (Felleisen, 1997), cross-reactivity with DNA of related species are possible. Because
T. foetus is regarded as host species speciﬁc, cross-reaction with trichomonads responsible for feline
trichomonosis and T. suis infections are of minor importance.
Positive predicive value (PPV) and negative predictive value (NPV) for cell culture and molecular
tests have not been established.
Feasibility
Parameter 3 – Type of sample matrix to be tested (blood, tissue, etc.)
For herd diagnosis, it is essential to sample bulls due to the fact that bulls remain persistently
infected (Yao, 2013). Preputial material is collected by sheath scraping combined with aspiration (using
brushes or insemination pipettes) or by sheath washing. Material is either inoculated into a transport
medium, in a transport or cell culture kit or submitted for DNA extraction and diagnostic PCR (OIE,
2017a). Detailed diagnostic procedures have also been described elsewhere (Sager et al., 2007).
Trichomonosis can also be diagnosed in dams although dams are normally only transiently infected;
parasites or parasite DNA can be detected in cervico-vaginal mucus collected by aspiration (Sager
et al., 2007).
Aborted material may contain T. foetus and the analysis of abomasal content is regarded as optimal
(BonDurant, 1985; Sager et al., 2007). The sample can be taken with sterile syringe and needle and
sent to the laboratory in the same syringe or can be inoculated in transport or cultured medium.
T. foetus can also be isolated from cotyledons. However, the high degree of contamination of this
material limits its use. Isolations can also be made with samples taken from fetal mouth. Swabbing the
mucosa of the tongue and roof of the mouth has been recommended (Case and Keefer, 1938).
Optimally, all types of samples should be added to transport media. They should be protected from
exposure to daylight and extremes of temperature, which should remain above 5°C and below 38°C
(Bryan et al., 1999; OIE, 2017a).
3.1.4.2. Article 7(d)(ii) Vaccination
Availability
Parameter 1 – Types of vaccines available on the market (live, inactivated, DIVA, etc.)
Commercial inactivated vaccines against trichomonosis in bovine prepared from whole organisms
are only available in the Americas but not in Europe.
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Parameter 2 – Availability/production capacity (per year)
In the US, an inactivated vaccine can be acquired in a monovalent formulation (Trich Guard®,
Boehringer Ingelheim, Germany) but also in a polyvalent formulation combined with
Campylobacter foetus subsp. venerealis and Leptospira (Trich Guard V5-L®, Boehringer Ingelheim,
Germany). In Argentina, an inactivated oily vaccine (Tricovac, Tandil Biological Laboratory, Argentina)
containing 5 9 107 trophozoites of T. foetus is available.
Effectiveness
Parameter 3 – Field protection as reduced morbidity (as reduced susceptibility to infection and/or to
disease)
The main objective of vaccines against trichomonosis in bovine is to eliminate T. foetus infection
from the reproductive tract before fetal loss occurs (approximately between 50 and 70 days post-
infection), without necessarily avoiding parasite colonisation of the epithelium during the ﬁrst 40 days
post-infection (BonDurant et al., 1993; BonDurant, 2005).
In heifers using whole-parasites-based vaccines (Kvasnicka et al., 1989, 1992; Herr et al., 1991;
Gault et al., 1995; Anderson et al., 1996; Cobo et al., 2002, 2004), a reduction in the number of
infected females, a shorter time of genital infection, and a higher percentage of pregnant females in
comparison with the control animals have been reported. In addition, a lower number of services (1.44
vs 1.73 in non-vaccinated, p < 0.16), higher percentage of pregnant animals at the ﬁrst service
(66.7% vs 33.3%, p < 0.05) (Hudson et al., 1993), with a reduction of embryo/fetal losses of 56.4%
(Kvasnicka et al., 1992) was observed. A recent study using TrichGuard® found that only 20% (4/20)
of the heifers in the placebo group gave birth to a live calf compared with 50% (10/20) of the
vaccinated heifers. Thus, embryonic or fetal loss was detected in 47% (9/19) vaccinated heifers and
71% (10/14) in the placebo group (p = 0.153) (Edmondson et al., 2017).
In bulls older than 5 years, the whole cell vaccine lacked a preventive or curative effect (Clark
et al., 1983a). Therefore, commercial TrichGuard® vaccine is not indicated for bulls (Herr et al., 1991;
BonDurant, 1997).
Parameter 4 – Duration of protection
In heifers, primovaccination and revaccination 2–4 weeks later should precede the breeding season
by 4 weeks. Annual revaccination before the breeding season is needed.
Feasibility
Parameter 5 – Way of administration
Inactivated vaccines are administered by the subcutaneous route.
3.1.4.3. Article 7(d)(iii) Medical treatments
Availability
Parameter 1 – Types of drugs available on the market
Various imidazoles were used to treat bulls, but none was both safe and effective. In addition, drug
resistant strains have been found (BonDurant, 2005; Rae and Crews, 2006). Currently, there is no
approved treatment for cattle infected with T. foetus because of concerns regarding toxic residues in
meat (BonDurant, 1997).
Parameter 2 – Availability/production capacity (per year)
There is no approved treatment for cattle infected with T. foetus.
Effectiveness
Parameter 3 – Therapeutic effects on the ﬁeld (effectiveness)
Currently, there is no approved treatment for cattle infected with T. foetus because of concerns
regarding toxic residues in meat (BonDurant, 1997). In addition, drug-resistant T. foetus strains have
been described (BonDurant, 2005; Rae and Crews, 2006). In the past, ipronidazole was probably the
most effective (Skirrow et al., 1985) but, due to its low pH, this drug frequently causes sterile
abscesses at injection sites. Moreover, systemic treatment with drugs like metronidazole or
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dimetridazole produces adverse side effects and development of resistant populations of trichomonads
(Campero et al., 1987).
Feasibility
Parameter 4 – Way of administration
There is no approved treatment for cattle infected with T. foetus.
3.1.4.4. Article 7(d)(iv) Biosecurity measures
Availability
Parameter 1 – Available biosecurity measures
For bulls destined for artiﬁcial insemination, quarantine and T. foetus periodic testing are routinely
used. In some areas of the world, as in the EU, speciﬁc regulations are applied to bovine semen trade
and to regulate the sanitary conditions of the collection centre and the animals (see Section 3.1.1.8).
In herds and areas where it is not possible to introduce AI and natural mating is the normal
practice, as in many areas where beef cattle are raised extensively, different policies have been
established to control the infection. There is no published information about the existence and results
of EU programmes for control of trichomonosis in bovine. On the contrary, in the US, state regulations
have endeavoured to control the endemic disease and to minimise economic losses by testing bulls
and allowing the importation only of T. foetus-free bulls for reproductive purposes while culling of
positive bulls (Yao, 2013). In the Argentinian region of La Pampa, with a bovine census close to
4 million head of cattle, more than 80% of the bulls have been tested twice each year. Positive bulls
could not be sold to other herds and movement was only allowed to the slaughter house. Under these
conditions, a signiﬁcant decrease in the number of infected herds and animals has been achieved in
this region in the last 10 years (Fort et al., 2016). Biosafety recommendations include quarantine and
testing replacement bulls and all the measures that help segregating infected from susceptible animals
(e.g. avoid communal grazing) (Campero and Gottstein, 2007).
Effectiveness
Parameter 2 – Effectiveness of biosecurity measures in preventing the pathogen introduction
Artiﬁcial insemination using semen from T. foetus non infected bulls is fully effective in preventing
trichomonosis. In fact, trichomonosis in bovine has almost disappeared or is anecdotic reported in
dairy cattle industries from western European countries, USA or Canada. However, the disease is still
present in many areas of the world, including those reported above, were cattle are raised on
communal grazing and natural mating is used.
Quarantine and testing of bulls, including culling of positive animals, and keep fences in a good
state is considered very effective in controlling disease in areas where natural mating is practised
(Collantes-Fernandez et al., 2014).
Feasibility
Parameter 3 – Feasibility of biosecurity measures
Biosecurity measures are feasible both at the international (EU countries) and farm levels.
3.1.4.5. Article 7(d)(v) Restrictions on the movement of animals and products
Availability
Parameter 1 – Available movement restriction measures
In the EU, there are no mandatory regulations for cattle movement regarding trichomonosis.
Speciﬁc regulations are applied to bovine semen trade and to regulate the sanitary conditions of the
collection centre and the animals. Speciﬁcally, bulls selected for entry into artiﬁcial insemination should
be tested in quarantine before admission to the centre and regular testing of animals in service are
included as basic measures to avoid the presence and dissemination of trichomonosis (Council
Directive 2003/43/EC).
In addition and due to the fact that T. foetus may be present in semen, recommendations for the
importation of cattle and bulls for breeding can be found in the Terrestrial Animal Health Code. In
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particular, emphasis has been placed on the measures applied to bull semen donor health status to
avoid dissemination and transmission of the disease (OIE, 2017b).
In the US, there are rules/regulations to reduce spread of the disease in 26 States (Szonyi et al.,
2012; Yao, 2013). The core of these regulations is testing bulls. It is also recommended not to
introduce cows or heifers of unknown health status during the breeding season. Similar to bulls,
heifers and cows must be acquired only from disease-free herds with records of excellence in
reproductive performance.
Effectiveness
Parameter 2 – Effectiveness of restriction of animal movement in preventing the between farm spread
Quarantine and testing of bulls, including culling those infected when they are introduced into the
herds, is effective in preventing spread of trichomonosis between farms. However, this measure will
not be effective enough to control the spread of the disease in endemic areas when other risk factors
are present such as cograzing, the use of communal bulls and a high proportion of old bulls (Yao,
2013; Collantes-Fernandez et al., 2014).
Regulations applied to bovine semen trade are fully effective in preventing spread of trichomonosis
by the use of artiﬁcial insemination.
Feasibility
Parameter 3 – Feasibility of restriction of animal movement
Restrictions of animal movement and products are feasible both at the international (EU countries)
and farm levels.
3.1.4.6. Article 7(d)(vi) Killing of animals
Availability
Parameter 1 – Available methods for killing animals
One of the most effective measures for controlling trichomonosis in beef herds practising natural
mating is the identiﬁcation and culling of infected bulls (Rae and Crews, 2006).
Effectiveness
Parameter 2 – Effectiveness of killing animals (at farm level or within the farm) for reducing/stopping
spread of the disease
Culling of infected bulls is effective in reducing/interrupting spread of the disease. However, as it
has been mentioned earlier, this measure will not be effective enough in endemic areas when other
risk factors are present such as cograzing, the use of communal bulls and a high proportion of old
bulls. A comparison of the prevalence of T. foetus infection after testing and culling of infected bulls
showed a sustainable reduction of T. foetus herd prevalence in an endemic area. Nevertheless, in the
second year after starting the study, the herd prevalence did not decrease, and new cases of infected
herds were observed (Collantes-Fernandez et al., 2014).
Feasibility
Parameter 3 – Feasibility of killing animals
Culling of infected bulls is feasible both at a regional and at farm level.
3.1.4.7. Article 7(d)(vii) Disposal of carcasses and other relevant animal by-products
Availability
Parameter 1 – Available disposal option
Not applicable – T. foetus is only transmitted by venereal route and the parasite is considered
incapable of forming cysts; its tenacity is extremely limited under environmental conditions and
carcasses or by-products represent no source of infection (BonDurant and Honigberg, 1994).
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Effectiveness
Parameter 2 – Effectiveness of disposal option
Not applicable – carcasses or by-products represent no source of infection.
Feasibility
Parameter 3 – Feasibility of disposal option
Not applicable – carcasses or by-products represent no source of infection.
3.1.5. Article 7(e) The impact of disease prevention and control measures
3.1.5.1. Article 7(e)(i) The direct and indirect costs for the affected sectors and the
economy as a whole
Parameter 1 – Cost of control (e.g. treatment/vaccine, biosecurity)
No data are available concerning costs of control, since it is difﬁcult to quantify and will depend
greatly on the size of the premise and the control method selected.
Parameter 2 – Cost of eradication (culling, compensation)
There is no compensation for culling of infected bulls. The cost of culling of infected bulls will
depend on the bull carcass weight, cull price data from the local sales yard, transport cost to
slaughterhouse and bull replacement costs. Culling/replacement bull cost was estimated about EUR
735 in a Spanish local breed (Collantes-Fernandez et al., 2014).
Parameter 3 – Cost of surveillance and monitoring
Cost of bull testing will vary depending on the laboratory and veterinary service fees. In a recent
study, trichomonad testing was estimated to cost about EUR 100/bull, including personnel costs
(Collantes-Fernandez et al., 2014). In Colorado cattle herds, a producer who has a 100 cow herd uses
one bull per 20 cows and lives 120 km from a veterinary clinic will incur about EUR 274 to test all of
the herd bulls for trichomonosis (Striegel et al., 2009).
Parameter 6 – Trade loss (bans, embargos, sanctions) by animal product
Not applicable.
Parameter 7 – Importance of the disease for the affected sector (% loss or € lost compared to business
amount of the sector)
In a study carried out in a local breed of cattle managed using traditional systems from northern
Spain (Collantes-Fernandez et al., 2014), T. foetus infection reduced income by 70% in herds primarily
as a result of prolonged calving intervals and calf crop reduction. Elongation of the calving interval
translates into an excess of days open, which causes losses about of 33% due to the cost of
maintaining open cows. The cost of a delay of 79 days could result in losses of approximately EUR 126
per cow. Calves from infected cows would be born 35 days later, being nearly 26 kg lighter at
weaning. Consequently, a producer could be losing nearly EUR 53 (~ 16.3%) for every late calf born in
a single season (Collantes-Fernandez et al., 2014). In an American study, trichomonosis was reported
to cause a 4–10% reduction in monetary returns per calf born and 5–35% reduction in ﬁnancial
returns per cow, compared to those exposed to a non-infected bull (Michi et al., 2016).
3.1.5.2. Article 7(e)(ii) The societal acceptance of disease prevention and control
measures
Considering the consequences of infection, following elimination of the infected bulls, an
improvement in reproductive performance was observed, and the reproductive data were equivalent to
those recorded in the non-infected herds, so this result would be anticipated to be socially very
acceptable (Collantes-Fernandez et al., 2014). In previous studies following the resolution of infection
in a herd, increases in calving percentages to 90% (Ball et al., 1987) and pregnancy percentages from
74% to 85% (Skirrow et al., 1985) were described.
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3.1.5.3. Article 7(e)(iii) The welfare of affected subpopulations of kept and wild animals
Parameter 1 – Welfare impact of control measures on domestic animals
The lack of effective vaccines and treatments in bulls may be a signiﬁcant constraint.
Parameter 2 – Wildlife depopulation as control measure
Not applicable – T. foetus has not been reported so far in wildlife species.
3.1.5.4. Article 7(e)(iv) The environment and biodiversity
Environment
Parameter 1 – Use and potential residuals of biocides or medical drugs in environmental compartments
(soil, water, feed, manure)
Not applicable.
Biodiversity
Parameter 2 – Mortality in wild species
Not applicable – T. foetus has not been reported so far in wildlife species.
3.2. Assessment according to Article 5 criteria
This section presents the results of the expert judgement on the criteria of Article 5 of the AHL about
trichomonosis (Table 4). The expert judgement was based on Individual and Collective Behavioural
Aggregation (ICBA) approach described in detail in the opinion on the methodology (EFSA AHAW Panel,
2017). Experts have been provided with information of the disease fact-sheet mapped into Article 5
criteria (see supporting information, Annex A), based on that the experts indicate their Y/N or ‘na’
judgement on each criterion of Article 5, and the reasoning supporting their judgement.
The minimum number of judges in the judgement was 12. The expert judgement was conducted
as described in the methodological opinion (EFSA AHAW Panel, 2017). For details on the interpretation
of the questions, see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017).
Table 4: Outcome of the expert judgement on the Article 5 criteria for trichomonosis
Criteria to be met by the disease:
According to AHL, a disease shall be included in the list referred to in point (b) of paragraph 1 of
Article 5 if it has been assessed in accordance with Article 7 and meets all of the following criteria
Final
outcome
A(i) The disease is transmissible Y
A(ii) Animal species are either susceptible to the disease or vectors and reservoirs thereof exist in
the Union
Y
A(iii) The disease causes negative effects on animal health or poses a risk to public health due to
its zoonotic character
Y
A(iv) Diagnostic tools are available for the disease Y
A(v) Risk-mitigating measures and, where relevant, surveillance of the disease are effective and
proportionate to the risks posed by the disease in the Union
Y
At least one criterion to be met by the disease:
In addition to the criteria set out above at points A(i)–A(v), the disease needs to fulﬁl at least one of the following criteria
B(i) The disease causes or could cause signiﬁcant negative effects in the Union on animal health, or
poses or could pose a signiﬁcant risk to public health due to its zoonotic character
Y
B(ii) The disease agent has developed resistance to treatments and poses a signiﬁcant danger to
public and/or animal health in the Union
N
B(iii) The disease causes or could cause a signiﬁcant negative economic impact affecting
agriculture or aquaculture production in the Union
Y
B(iv) The disease has the potential to generate a crisis or the disease agent could be used for the
purpose of bioterrorism
N
B(v) The disease has or could have a signiﬁcant negative impact on the environment, including
biodiversity, of the Union
N
Colour code: green = consensus (Yes/No).
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3.2.1. Outcome of the assessment of trichomonosis according to criteria of
Article 5(3) of the AHL on its eligibility to be listed
As from the legal text of the AHL, a disease is considered eligible to be listed as laid down in Article
5 if it fulﬁls all criteria of the ﬁrst set from A(i) to A(v) and at least one of the second set of criteria
from B(i) to B(v). According to the assessment methodology (EFSA AHAW Panel, 2017), a criterion is
considered fulﬁlled when the outcome is ‘Yes’. According to the results shown in Table 4, trichomonosis
complies with all criteria of the ﬁrst set and with two criteria of the second set, therefore it is
considered eligible to be listed for Union intervention as laid down in Article 5(3) of the AHL.
3.3. Assessment according to Article 9 criteria
This section presents the results of the expert judgement on the criteria of Annex IV referring to
categories as in Article 9 of the AHL about trichomonosis (Tables 5, 6, 7, 8 and 9). The expert
judgement was based on ICBA approach described in detail in the opinion on the methodology.
Experts have been provided with information of the disease fact-sheet mapped into Article 9 criteria
(see supporting information, Annex A), based on that the experts indicate their Y/N or ‘na’ judgement
on each criterion of Article 9 and the reasoning supporting their judgement.
The minimum number of judges in the judgement was 12. The expert judgement was conducted
as described in the methodological opinion (EFSA AHAW Panel, 2017). For details on the interpretation
of the questions, see Appendix B of the methodological opinion (EFSA AHAW Panel, 2017).
Table 5: Outcome of the expert judgement related to the criteria of section 1 of Annex IV
(category A of Article 9) for trichomonosis (CI: current impact; PI: potential impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final
outcome
1 The disease is not present in the territory of the Union OR present only in exceptional cases
(irregular introductions) OR present only in a very limited part of the territory of the Union
N
2.1 The disease is highly transmissible N
2.2 There are possibilities of airborne or waterborne or vector-borne spread N
2.3 The disease affects multiple species of kept and wild animals OR single species of kept
animals of economic importance
Y
2.4 The disease may result in high morbidity and signiﬁcant mortality rates N
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following criteria
3 The disease has a zoonotic potential with signiﬁcant consequences on public health,
including epidemic or pandemic potential OR possible signiﬁcant threats to food safety
N
4(CI) The disease has a signiﬁcant impact on the economy of the Union, causing substantial
costs, mainly related to its direct impact on the health and productivity of animals
NC
4(PI) The disease has a signiﬁcant impact on the economy of the Union, causing substantial
costs, mainly related to its direct impact on the health and productivity of animals
Y
5(a)(CI) The disease has a signiﬁcant impact on society, with in particular an impact on labour markets N
5(a)(PI) The disease has a signiﬁcant impact on society, with in particular an impact on labour markets N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(c)(CI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
Colour code: green = consensus (Yes/No), yellow = non-consensus (NC).
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Table 6: Outcome of the expert judgement related to the criteria of section 2 of Annex IV
(category B of Article 9) for trichomonosis (CI: current impact; PI: potential impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final
outcome
1 The disease is present in the whole OR part of the Union territory with an endemic character
AND (at the same time) several Member States or zones of the Union are free of the disease
N
2.1 The disease is moderately to highly transmissible Y
2.2 There are possibilities of airborne or waterborne or vector-borne spread N
2.3 The disease affects single or multiple species Y
2.4 The disease may result in high morbidity with in general low mortality N
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following criteria
3 The disease has a zoonotic potential with signiﬁcant consequences on public health,
including epidemic potential OR possible signiﬁcant threats to food safety
N
4(CI) The disease has a signiﬁcant impact on the economy of the Union, causing substantial
costs, mainly related to its direct impact on the health and productivity of animals
NC
4(PI) The disease has a signiﬁcant impact on the economy of the Union, causing substantial
costs, mainly related to its direct impact on the health and productivity of animals
Y
5(a)(CI) The disease has a signiﬁcant impact on society, with in particular an impact on labour
markets
N
5(a)(PI) The disease has a signiﬁcant impact on society, with in particular an impact on labour
markets
N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(c)(CI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
Colour code: green = consensus (Yes/No), yellow = non-consensus (NC).
Table 7: Outcome of the expert judgement related to the criteria of section 3 of Annex IV
(category C of Article 9) for trichomonosis (CI: current impact; PI: potential impact)
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final
outcome
1 The disease is present in the whole OR part of the Union territory with an endemic
character
Y
2.1 The disease is moderately to highly transmissible Y
2.2 The disease is transmitted mainly by direct or indirect transmission Y
2.3 The disease affects single or multiple species Y
2.4 The disease usually does not result in high morbidity and has negligible or no mortality
AND often the most observed effect of the disease is production loss
Y
At least one criterion to be met by the disease:
In addition to the criteria set out above at points 1–2.4, the disease needs to fulﬁl at least one of the following criteria
3 The disease has a zoonotic potential with signiﬁcant consequences on public health, or
possible signiﬁcant threats to food safety
N
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3.3.1. Non-consensus-questions
This section displays the assessment related to each criterion of Annex IV referring to the
categories of Article 9 of the AHL where no consensus was achieved in form of tables (Table 10). The
proportion of Y, N or ‘na’ answers is reported, followed by the list of different supporting views for
each answer.
4(CI) The disease has a signiﬁcant impact on the economy of parts of the Union, mainly related
to its direct impact on certain types of animal production systems
NC
4(PI) The disease has a signiﬁcant impact on the economy of parts of the Union, mainly related
to its direct impact on certain types of animal production systems
Y
5(a)(CI) The disease has a signiﬁcant impact on society, with in particular an impact on labour
markets
N
5(a)(PI) The disease has a signiﬁcant impact on society, with in particular an impact on labour
markets
N
5(b)(CI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(b)(PI) The disease has a signiﬁcant impact on animal welfare, by causing suffering of large
numbers of animals
N
5(c)(CI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(c)(PI) The disease has a signiﬁcant impact on the environment, due to the direct impact of the
disease OR due to the measures taken to control it
N
5(d)(CI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
5(d)(PI) The disease has a signiﬁcant impact on a long-term effect on biodiversity or the protection
of endangered species or breeds, including the possible disappearance or long-term
damage to those species or breeds
N
Colour code: green = consensus (Yes/No), yellow = non-consensus (NC).
Table 8: Outcome of the expert judgement related to the criteria of section 4 of Annex IV
(category D of Article 9) for trichomonosis
Criteria to be met by the disease:
The disease needs to fulﬁl all of the following criteria
Final
outcome
D The risk posed by the disease in question can be effectively and proportionately mitigated
by measures concerning movements of animals and products in order to prevent or limit its
occurrence and spread
Y
The disease fulﬁls criteria of sections 1, 2, 3 or 5 of Annex IV of AHL Y
Colour code: green = consensus (Yes/No).
Table 9: Outcome of the expert judgement related to the criteria of section 5 of Annex IV
(category E of Article 9) for trichomonosis
Diseases in category E need to fulﬁl criteria of sections 1, 2 or 3 of Annex IV of AHL
and/or the following:
Final
outcome
E Surveillance of the disease is necessary for reasons relating to animal health, animal
welfare, human health, the economy, society or the environment (If a disease fulﬁls the
criteria as in Article 5, thus being eligible to be listed, consequently category E would
apply)
Y
Colour code: green = consensus (Yes/No).
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Reasoning supporting the judgement
Supporting Yes for 4 (cat. A, B):
• Trichomonosis in bovine decreases productivity of cattle by inducing reduced conception rates
and calf crops, increased days to conception, extended calving seasons, increased costs of
replacement bulls, loss of genetic potential due to culling and lighter weaning weights. This
has an impact on the economy of the Union, especially if the infection is present in countries
with extensive beef production.
Supporting No for 4 (cat. A, B):
• In EU countries, the disease presence has dramatically decreased in recent years or even
eradicated (in dairy cattle). The impact of the disease is limited to some areas of the EU where
beef cattle are breeding by natural service. It is therefore not signiﬁcant at EU level.
Supporting Yes for 4 (cat. C):
• The impact on the EU economy is signiﬁcant in some areas of the EU where in extensive beef
breeding production systems the use of AI is often impractical and thus natural service is
practised.
Supporting No for 4 (cat. C):
• The disease affects a certain type of production system, but the impact is not signiﬁcant on
the economy at EU level.
3.3.2. Outcome of the assessment of criteria in Annex IV for trichomonosis for
the purpose of categorisation as in Article 9 of the AHL
As from the legal text of the AHL, a disease is considered ﬁtting in a certain category (A, B, C, D or
E corresponding to point (a) to point (e) of Article 9(1) of the AHL) if it is eligible to be listed for Union
intervention as laid down in Article 5(3) and fulﬁls all criteria of the ﬁrst set from 1 to 2.4 and at least
one of the second set of criteria from 3 to 5(d) as shown in Tables 5–9. According to the assessment
methodology (EFSA AHAW Panel, 2017), a criterion is considered fulﬁlled when the outcome is ‘Yes’.
With respect to different type of impact where the assessment is divided into current and potential
impact, a criterion will be considered fulﬁlled if at least one of the two outcomes is ‘Y’ and, in case of
no ‘Y’, the assessment is inconclusive if at least one outcome is ‘NC’.
A description of the outcome of the assessment of criteria in Annex IV for trichomonosis for the
purpose of categorisation as in Article 9 of the AHL is presented in Table 11.
Table 10: Outcome of the expert judgement related to criterion 4(CI) of Article 9
Question
Final
outcome
Response
Y (%) N (%) Na (%)
4 (cat. A, B) The disease has a signiﬁcant impact on the economy of
the Union, causing substantial costs, mainly related to its
direct impact on the health and productivity of animals
NC 25 75 0
4 (cat. C) The disease has a signiﬁcant impact on the economy of
parts of the Union, mainly related to its direct impact on
certain types of animal production systems
NC 58 42 0
NC: non-consensus; number of judges: 12.
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According to the assessment here performed, trichomonosis complies with the following criteria of
the sections 1–5 of Annex IV of the AHL for the application of the disease prevention and control rules
referred to in points (a)–(e) of Article 9(1):
1) To be assigned to category A, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment trichomonosis complies only with criterion 2.3.
To be eligible for category A, a disease needs to comply additionally with one of the criteria
of the second set (3, 4, 5a–d) and trichomonosis complies with criterion 4, but not with
criteria 3, 5a, 5b, 5c and 5d.
2) To be assigned to category B, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment trichomonosis complies with criteria 2.1 and
2.3, but not with criteria 1, 2.2 and 2.4. To be eligible for category B, a disease needs to
comply additionally with one of the criteria of the second set (3, 4, 5a–d) and trichomonosis
complies with criterion 4 but not with criteria 3, 5a, 5b, 5c and 5d.
3) To be assigned to category C, a disease needs to comply with all criteria of the ﬁrst set
(1, 2.1–2.4) and according to the assessment trichomonosis complies with all of them. To be
eligible for category C, a disease needs to comply additionally with one of the criteria of the
second set (3, 4, 5a–d) and trichomonosis complies with criterion 4 but not with criteria 3,
5a, 5b, 5c and 5d.
4) To be assigned to category D, a disease needs to comply with criteria of sections 1, 2, 3 or 5
of Annex IV of the AHL and with the speciﬁc criterion D of section 4, with which
trichomonosis complies.
5) To be assigned to category E, a disease needs to comply with criteria of sections 1, 2 or 3 of
Annex IV of the AHL and/or the surveillance of the disease is necessary for reasons relating
to animal health, animal welfare, human health, the economy, society or the environment.
The latter is applicable if a disease fulﬁls the criteria as in Article 5, with which trichomonosis
complies.
3.4. Assessment of Article 8
This section presents the results of the assessment on the criteria of Article 8(3) of the AHL about
trichomonosis. The Article 8(3) criteria are about animal species to be listed, as it reads below:
‘3. Animal species or groups of animal species shall be added to this list if they are affected or if
they pose a risk for the spread of a speciﬁc listed disease because:
Table 11: Outcome of the assessment of criteria in Annex IV for trichomonosis for the purpose of
categorisation as in Article 9 of the AHL
Category
Article 9 criteria
1° set of criteria 2° set of criteria
1 2.1 2.2 2.3 2.4 3 4 5a 5b 5c 5d
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a) they are susceptible for a speciﬁc listed disease or scientiﬁc evidence indicates that such
susceptibility is likely; or
b) they are vector species or reservoirs for that disease, or scientiﬁc evidence indicates that such
role is likely’.
For this reason the assessment on Article 8 criteria is based on the evidence as extrapolated from
the relevant criteria of Article 7, i.e. the ones related to susceptible and reservoir species or routes of
transmission, which cover also possible role of biological or mechanical vectors.4 According to the
mapping, as presented in Table 5, Section 3.2 of the scientiﬁc opinion on the ad hoc methodology
(EFSA AHAW Panel, 2017), the main animal species to be listed for trichomonosis according to the
criteria of Article 8(3) of the AHL are as displayed in Table 12.
4. Conclusions
TOR 1: for each of those diseases an assessment, following the criteria laid down in Article 7 of
the AHL, on its eligibility of being listed for Union intervention as laid down in Article 5(3) of the AHL;
• According to the assessment here performed, trichomonosis complies with all criteria of the
ﬁrst set and with two criteria of the second set and therefore can be considered eligible to be
listed for Union intervention as laid down in Article 5(3) of the AHL.
TOR 2a: for each of the diseases which was found eligible to be listed for Union intervention, an
assessment of its compliance with each of the criteria in Annex IV to the AHL for the purpose of
categorisation of diseases in accordance with Article 9 of the AHL;
• According to the assessment here performed, trichomonosis meets the criteria as in sections 3,
4 and 5 of Annex IV of the AHL, for the application of the disease prevention and control rules
referred to in points (c), (d) and (e) of Article 9(1) of the AHL.
TOR 2b: for each of the diseases which was found eligible to be listed for Union intervention, a list
of animal species that should be considered candidates for listing in accordance with Article 8 of the
AHL.
• According to the assessment here performed, the animal species that can be considered to be
listed for trichomonosis according to Article 8(3) of the AHL is cattle as susceptible and
reservoir, as reported in Table 12 in Section 3.4 of the present document.
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AHAW EFSA Panel on Animal Health and Welfare
AHL Animal Health Law
AI Artiﬁcial insemination
ICBA Individual and Collective Behavioural Aggregation
ITS internal transcribed spacer
LSU large subunit
NPV negative predictive value
OIE World Organization for Animal Health
PCR polymerase chain reaction
PPV positive predictive value
rDNA recombinant DNA
RFLP restriction fragment length polymorphism
rRNA ribosomal ribonucleic acid
Se diagnostic sensitivity
Sp diagnostic speciﬁcity
SSCP single-strand conformation polymorphism
SSU small subunit
ToR Terms of Reference
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Appendix A – Diagnosis of trichomonosis
Table A.1: PCRs assays for Trichomonas detection
Target Type of PCR Name of primer
Name of
probe (type
of probe)
Reported speciﬁcity
Reported
sensitivity
Remarks Reference
ITS1/5.8S rRNA/
ITS2
End-point TFR1, TFR2 NA Ampliﬁes T. foetus, T. suis,
T. mobilensis, T. vaginalis,
T. gallinae, T. tenax, P. hominis
(Felleisen et al., 1998). No
ampliﬁcation of bacterial DNA,
or puriﬁed bovine genomic DNA
1 or a few protozoa Also referred to as
pan-trichomonad PCR
Felleisen (1997)
ITS1/5.8S rRNA/
ITS2
End-point TFR3, TFR4 NA Ampliﬁes T. foetus, T. suis,
T. mobilensis
1 or a few protozoa Often referred to as
T. foetus speciﬁc PCR
Felleisen et al.
(1998)
18S rRNA, ITS1,
5.8S rRNA
End-point TF211A, TF211B NA Does not amplify
Mycoplasma bovigenitalium,
Ureaplasma diversum or bovine
genomic DNA
1 pg Reported to produce
few unspeciﬁc DNA
bands
Nickel et al.
(2002)
ITS1-5.8S rRNA-
ITS2
End-point Tricho-F/Tricho-R NA Ampliﬁes T. foetus, T. suis,
T. mobilensis based on in silico
analyses; ampliﬁed
Pentatrichomonas hominis
NA Used in human
samples and in a
study on cats (Proﬁzi
et al., 2013)
Jongwutiwes et al.
(2000) and
Duboucher et al.
(2006)
18S rRNA, ITS1
and 5.8S rRNA
End-point Forward, reverse NA Ampliﬁes T. foetus but also
trichomonad DNA from a
variety of genera; T. foetus
(157 bp), Tetratrichomonas
spp. (170–175 bp),
Pentatrichomonas hominis
(142 bp)
Accurate typing is
possible from both
the 1.0 and 0.1 pg
templates
Using diagnostic size
variants from within
the ITS1 region.
Incorporation of a
ﬂuorescently labelled
primer enables high
sensitivity and rapid
assessment of results
for species
identiﬁcation
Grahn et al.
(2005)
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Target Type of PCR Name of primer
Name of
probe (type
of probe)
Reported speciﬁcity
Reported
sensitivity
Remarks Reference
18S rRNA, ITS1
and 5.8S rRNA
End-point Forward, reverse
5.8S primer
NA Ampliﬁed T. foetus (367 bp),
Tetratrichomonas sp. (379 bp),
Pentatrichomonas sp. (333 bp),
T. gallinae (364 bp), and
T. vaginalis (363 bp)
0.1 pg Analysis in a 2%
agarose gel and by
using ﬂuorescent-
labelled primers and
6% polyacrylamide
gels; disadvantage:
too much template
makes typing difﬁcult
or impossible;
advantage: low costs
Frey et al. (2009)
ITS1/5.8S
rRNA/ITS2
End-point
nested
TFR3, TFR4
(external); TFITS-F,
TFITS-R (internal)
NA T. foetus-speciﬁc 1 organism (70%
positive), 10
organisms (90%
positive), 100
organisms (100%
positive); 10
organisms per
200 mg of faeces
(90% positive); 100
organisms per
200 mg of faeces
(100% positive)
Single tube nested
PCR
Gookin et al.
(2002)
ITS1/5.8S rRNA/
ITS2
Real-time TFR3, TFR 4 NA T. foetus-speciﬁc SYBR qPCR Mueller et al.
(2015)
5.8S rRNA Real-time T.foeForward (TFF2),
T.foeReverse (TFR2)
T.foeProbe
(50FAM/30MGB-
NFQ)
Ampliﬁes T. foetus, T. suis,
T. mobilensis
3 fg DNA, 0.1-1
cells per assay
50 Taq nuclease assay
using a 30 minor
groove binder-DNA
probe; no need for
post-ampliﬁcation
processing
McMillen and Lew
(2006)
SSU rDNA End-point
nested
External: 16Sl; 16Sr;
Internal: TN3, TN4
NA Ampliﬁes Trichomonas sp. NA NA Robinson et al.
(2010)
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Target Type of PCR Name of primer
Name of
probe (type
of probe)
Reported speciﬁcity
Reported
sensitivity
Remarks Reference
SSU rDNA End-point Tgf, Tgr NA Ampliﬁes T. gallinarum 1 protozoon per
assay
Cross-reactions with
T. gallinae. No cross-
reactions were
observed with samples
from other protozoa
(Toxoplasma gondii,
Eimeria tenella,
Cryptosporidium spp.,
E. invadens and
E. ranarum)
Grabensteiner and
Hess (2006)
Not reported End-point +
southernblot
by probe
TF1, TF2 Probe for
Southern blot
Ampliﬁes T. foetus 10 or occasionally
fewer protozoa
Southern blot
necessary to identify
speciﬁc band. A
400 bp product from
bovine genomic DNA
is ampliﬁed. Multiple
ampliﬁcation products
from DNA from a
related organism,
T. vaginalis; Southern
blot is negative for
T. vaginalis)
Ho et al. (1994)
www.efsa.europa.eu/efsajournal 36 EFSA Journal 2017;15(10):4992
AHL assessment on trichomonosis
Annex A – Mapped fact-sheet used in the individual judgement on
trichomonosis
Annex A can be found in the online version of this output (‘Supporting information’ section):
https://doi.org/10.2903/j.efsa.2017.4992
AHL assessment on trichomonosis
www.efsa.europa.eu/efsajournal 37 EFSA Journal 2017;15(10):4992
